Evidence map›Paper›PMID 33142704›Full record

ReviewBiomedicines2020

Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis.

Raquel Sanabria-de la Torre, Ana Fernández-González, María I Quiñones-Vico, Trinidad Montero-Vilchez, Salvador Arias-Santiago

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Antibiotics againstPharmaceutics · 2024
    Article
  8. Antioxidants (Basel, Switzerland) · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The Role of Exosomes Derived From Mesenchymal Stromal Cells in Dermatology.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Raquel Sanabria-de la TorreCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Ana Fernández-GonzálezCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
María I Quiñones-VicoCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Trinidad Montero-VilchezBiosanitary Institute of Granada (ibs.GRANADA), 18014 Granada, Spain.
Salvador Arias-SantiagoCell Production and Tissue Engineering Unit, Virgen de las Nieves University Hospital, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ESUniversidad de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aims to be an update of Bioengineered Artificial Skin Substitutes (BASS) applications. At the first moment, they were created as an attempt to replace native skin grafts transplantation. Nowadays, these in vitro models have been increasing and widening their application areas, becoming important tools for research. This study is focus on the ability to design in vitro BASS which have been demonstrated to be appropriate to develop new products in the cosmetic and pharmacology industry. Allowing to go deeper into the skin disease research, and to analyze the effects provoked by environmental stressful agents. The importance of BASS to replace animal experimentation is also highlighted. Furthermore, the BASS validation parameters approved by the OECD (Organisation for Economic Co-operation and Development) are also analyzed. This report presents an overview of the skin models applicable to skin research along with their design methods. Finally, the potential and limitations of the currently available BASS to supply the demands for disease modeling and pharmaceutical screening are discussed.

Indexed as

animal experimentationatopic dermatitisbioengineered artificial skin substitutesfibroblastskeratinocytesproduct testingpsoriasisregenerative medicinetissue engineeringtransepidermal water loss

Identifiers

PMID33142704
PMCPMC7694072
OpenAlexW3096897083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.